OBJECTIVE: Gestational diabetes mellitus is characterized by progressive insulin resistance. Adipocytokines are thought to be associated with insulin resistance. This cross-sectional study evaluated the associations between serum concentrations of several adipocytokines and insulin resistance at different stages of glucose tolerance in pregnancy, using the homeostasis model assessment of insulin resistance (HOMA-IR) as a reference. METHODS: According to oral glucose tolerance test results, 74 pregnant women were divided into three groups: normal glucose tolerance (n = 25); intermediate glucose tolerance (n = 19); gestational diabetes mellitus (n = 30). Adiponectin, leptin, resistin, visfatin and retinolbinding protein 4 (RBP4) concentrations were measured using enzyme-linked immuno sorbent assays. RESULTS: Groups were comparable regarding age, week of gestation and body mass index before gestation.
Introduction
Pregnancy is characterized by progressive insulin resistance, the degree of which is further accentuated in women with gestational diabetes mellitus, 1 which is an increasingly common metabolic complication in pregnancy. 1 The assessment of insulin resistance in pregnancy is important since it enables the identification of those at higher risk of adverse pregnancy outcomes and future development of type 2 diabetes mellitus. 1 The gold standard method for measuring insulin resistance is the hyperinsulinaemiceuglycaemic clamp technique. 2 This method provides an accurate in vivo assessment of insulin action but is invasive, time consuming and difficult to perform, Serum adipocytokine concentrations and gestational diabetes especially in pregnancy. The homeostasis model assessment of insulin resistance (HOMA-IR) is an alternative, simple and noninvasive method that provides an estimate of insulin sensitivity from steadystate glucose and insulin concentrations, measured under fasting conditions. 3 It generally correlates well with the clamp technique and has been used as a standard method for assessing insulin resistance. 4 Several studies have investigated the role of adipocytokines in pregnancy. 5 -21 Some adypocytokines -including adiponectin, leptin, resistin, visfatin and retinol-binding protein 4 (RBP4) -have been investigated as potential biomarkers that may permit a simple and noninvasive assessment of insulin resistance in pregnancy. 5, 11, 15, 18, 20 Data concerning these adipocytokines and their associations with insulin resistance in normal pregnancy and gestational diabetes mellitus are, however, limited and somewhat contradictory.
The aim of the present study was to evaluate the associations between different degrees of glucose tolerance in pregnancy and serum concentrations of adiponectin, leptin, resistin, visfatin and RBP4, using HOMA-IR as a reference.
Patients and methods

STUDY POPULATION AND DESIGN
This cross-sectional study was conducted between May 2007 and January 2009. Pregnant women who attended the diabetes outpatient clinic at the University Medical Centre Ljubljana, Ljubljana, Slovenia, as part of a standard screening procedure during pregnancy, were sequentially enrolled into the study. Exclusion criteria were: (i) concomitant treatment or disease; (ii) prior or current use of medications that interfere with insulin sensitivity; (iii) history of diabetes mellitus; and (iv) aged < 18 or > 45 years. The study protocol was approved by The National Medical Ethics Committee of the Republic of Slovenia, Ljubljana, Slovenia, and conducted in accordance with the Declaration of Helsinki and its amendments. All participants were informed of the study aims and provided written consent.
For each participant, weight and height were measured and body mass index (BMI) was calculated. Data regarding age, week of gestation and prepregnancy weight were collected. A fasting oral glucose tolerance test was performed with 100 g of glucose given in the morning. Glucose concentration cut-off values were 5.3 mmol/l at the start of the test, 10.0 mmol/l after 60 min, 8.6 mmol/l after 120 min and 7.8 mmol/l after 180 min. Intermediate glucose tolerance was diagnosed if one value was met or exceeded; gestational diabetes mellitus was diagnosed if two or more values were met or exceeded. 22 The pregnant women were divided into three groups: (i) normal glucose tolerance (NGT group); (ii) intermediate glucose tolerance (IGT group); (iii) gestational diabetes mellitus (GDM group).
SERUM GLUCOSE, INSULIN AND ADIPOCYTOKINE MEASUREMENTS
Fasting blood samples were collected in ethylenediaminetetra-acetic acid-coated tubes before the oral glucose tolerance test was undertaken. Blood was centrifuged at 2800 g for 10 min at 4°C and the serum was stored at -80°C until analysis. Glucose concentrations were determined using the standard glucose oxidase method ( 
STATISTICAL ANALYSES
The Shapiro-Wilk test was used to verify assumptions of normality or log-normality. Between-group differences were assessed with analysis of variance for normally and lognormally distributed variables, and the Kruskal-Wallis test for variables that were not normally or log-normally distributed. Results for normally and log-normally distributed parameters are presented as mean ± SD. Results for not normally distributed parameters are presented as median and interquartile range (IQR). Analysis of contrasts was used to perform a post hoc analysis. Since the contrasts were not orthogonal, Holm's method was used to control the false discovery rate. Correlation between numerical variables was estimated with Pearson's correlation coefficient. Statistical analyses were performed using R language for statistical computing. 23 A P-value of < 0.05 was considered statistically significant.
Results
A total of 74 pregnant women were enrolled into the study (mean ± SD age 30.76 ± 4.27 years) and divided into three groups: NGT group (n = 25); IGT group (n = 19); GDM group (n = 30). Women in the GDM group were younger than those in the IGT or NGT groups, but the difference was not statistically significant ( Table 1 ). All three groups were comparable regarding the week of gestation (mean ± SD gestation 26.81 ± 3.52 weeks). The median BMI before pregnancy was 22.68 kg/m 2 (IQR 20.75 -26.79 kg/m 2 ) and during pregnancy was 26.57 kg/m 2 (IQR 23.82 -29.71 kg/m 2 ). Women in the GDM group had a higher BMI before pregnancy compared with women in the IGT and NGT groups, but the differences were not significant. The between-group difference in BMI during pregnancy was not statistically significant (P = 0.05).
There was a statistically significant between-group difference in HOMA-IR (P = 0.02; Table 1 ). Pairwise comparisons between the groups were significant for the NGT versus the IGT group (P = 0.03), and the NGT versus the GDM group (P = 0.02), but there was no significant difference between the IGT and GDM groups.
There were no statistically significant between-group differences in serum adiponectin, leptin, resistin, visfatin or RBP4 concentrations. There was a significant overall correlation between the serum leptin concentration and the HOMA-IR (r = 0.42, P < 0.01). Leptin concentrations in the NGT and GDM groups correlated significantly with HOMA-IR (r = 0.48, P = 0.01; r = 0.47, P < 0.01, respectively), but there was no correlation between the leptin concentration and the HOMA-IR in the IGT group. There was no correlation between HOMA-IR and serum concentrations of adiponectin, resistin, visfatin or RBP4. 5 -21 The current study found that maternal serum concentrations of adiponectin, leptin, resistin, visfatin and RBP4 were not sufficiently sensitive to replace HOMA-IR in the assessment of insulin resistance across various degrees of glucose tolerance in pregnancy.
Discussion
Studies have reported limited and
Adiponectin concentrations are known to be lower in insulin-resistant states such as obesity and type 2 diabetes mellitus. 24 In some studies, adiponectin concentrations have also been shown to be lower in women with gestational diabetes mellitus compared with those who have a normal pregnancy. 5 -8 Lower adiponectin concentrations were observed in women with gestational diabetes mellitus compared with those with normal glucose tolerance in the present study, but the difference did not reach statistical significance. This may be due to the small study cohort, or a lower degree of insulin resistance being observed in this cohort compared with that seen in other studies. 5, 6 The discrepancy may also be related to interstudy variations in gestational age and demographic characteristics.
Studies investigating resistin, visfatin and leptin in women with gestational diabetes mellitus have given conflicting results, 9 -18 and their roles remain a matter of debate. The current study found no significant between-group differences regarding these three adipocytokine concentrations. Some studies have found increased 9,10 or decreased 11 serum resistin concentrations in women with gestational diabetes mellitus compared with women who have normal glucose tolerance. There were no significant differences between the groups regarding resistin in the current study, which is in accordance with the findings of others. 12 It has been shown that serum resistin concentrations decrease after delivery, 9, 11 possibly due to the effect of the placenta and its hormones, and this may explain these contradictory findings.
Women with gestational diabetes mellitus had the highest (although not significantly different) serum visfatin concentrations in the current study. This is in accordance with other reports, where the differences reached statistical significance. 13, 14 In contrast, other investigators have reported lower visfatin concentrations in pregnant women with gestational diabetes mellitus compared with those who have normal glucose tolerance. 15, 16 Szamatowicz et al. 17 found significantly higher serum visfatin concentrations in pregnant women compared with nonpregnant controls, irrespective of their glucose tolerance status. Overall, visfatin and resistin do not seem to represent reliable clinical biomarkers for the prediction of metabolic complications in pregnancy.
The role of leptin in pregnancy remains unclear. Some studies have reported significantly higher leptin concentrations in women with gestational diabetes mellitus compared with those who have normal glucose tolerance. 6, 18 Another study, however, found no difference between these groups. 5 Leptin concentrations were lower in women in the NGT group compared with women in groups IGT and GDM in the current study, but the differences were not statistically significant. Leptin was the only adipocytokine to correlate with HOMA-IR in the current study, but there was no association with the degree of glucose tolerance. Leptin concentrations have been shown to decrease after delivery, 13 suggesting that they have an important placental influence.
The adipocytokine RBP4 has also been proposed as a marker of insulin resistance, 20 In some studies, RBP4 concentrations were increased in women with gestational diabetes mellitus, 19, 20 while another study reported lower concentrations in such women compared with normal pregnant controls. 21 The relationship between the serum RBP4 concentration and insulin resistance is unclear. In the present study, serum RBP4 concentrations were lower in women in the GDM group compared with those in the NGT group, but the difference was not significant. In addition, there was no correlation between the RBP4 concentration and HOMA-IR, in accordance with the findings of others. 19, 21 The marked variability in RBP4 concentrations observed in this study may be due to the laboratory method used, since considerable discrepancies exist between different RBP4 assays. 21 Taken together, these findings suggest that RBP4 concentrations did not provide a reliable estimation of insulin resistance as assessed by HOMA-IR in this population. Larger studies and new laboratory methods with higher specificity are required, in order to determine the potential clinical implications of serum RBP4 concentrations and its involvement in the regulation of insulin resistance in pregnancy.
To our knowledge, this is the first study to investigate such a broad set of potentially clinically relevant adipocytokines across different degrees of glucose tolerance in pregnant women. The three groups of pregnant women were comparable regarding age, week of gestation, BMI before pregnancy and BMI during pregnancy.
This study had several limitations. The adipocytokine findings could not be compared with hyperinsulinaemiceuglycaemic clamp data, since this invasive procedure is generally not used in this vulnerable population of pregnant women. When investigating the between-group differences, the majority of analyses did not reach statistical significance, possibly due to the small study cohort, although the number of participants was sufficient for a medium standardized effect-size. The endpoints used in this study could be applied to further research and clinical interpretations, as they suggested that serum adipocytokine concentrations in pregnancy are influenced by a broad spectrum of factors.
In conclusion, maternal serum concentrations of adiponectin, leptin, resistin, visfatin and RBP4 were not associated with the degree of glucose tolerance in pregnancy. These adipocytokines are also not sufficiently sensitive to replace HOMA-IR in the assessment of insulin resistance in pregnancy.
